Mortality due to prostate cancer in the Spanish arm of the European Randomized Study of Screening for Prostate Cancer (ERSPC). Results after a 15-year follow-up;Mortalidad por cáncer de próstata en la rama española del European Randomized Study of Screening for Prostate Cancer (ERSPC). Resultados tras 15 años de seguimiento

Actas Urologicas Espanolas

Volumn 36, Issue 7, 2012, Pages 403-409

  Lujan M ^a,b   Paez A ^b,c   Berenguer, A ^b,d   Rodriguez J A ^e  

^a HOSPITAL INFANTA CRISTINA   (Spain)

^b Rama Española Del European Randomized Study of Screening for Prostate Cancer   (Spain)

^c HOSPITAL UNIVERSITARIO DE FUENLABRADA   (Spain)

^d Hospital Universitario Madrid Norte Sanchinarro   (Spain)

^e Instituto Nacional de Estadistica   (Spain)

Author keywords

Mortality; Population screening; Prostate cancer

Indexed keywords

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EARLY DIAGNOSIS; EUROPE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; MORTALITY; PROSTATE TUMOR; RANDOMIZED CONTROLLED TRIAL; SPAIN; TIME;

AGED; EARLY DETECTION OF CANCER; EUROPE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; SPAIN; TIME FACTORS;

EID: 84863517227     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acuro.2011.10.013     Document Type: Article

References (24)

1. R. Siegel, E. Ward, O. Brawley, and A. Jemal Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths CA Cancer J Clin 61 2011 212 236
2. C.G. Roehrborn, and L.K. Black The economic burden of prostate cancer BJU Int 108 2011 806 813
3. S.J. Otto, S.M. Moss, L. Maattanen, M. Roobol, M. Zappa, and V. Nelen PSA levels and cancer detection rate by centre in the European Randomized Study of Screening for Prostate Cancer Eur J Cancer 46 2010 3053 3060
4. M.J. Sanchez, T. Payer, A.R. De, N. Larranaga, R. Capocaccia, and C. Martinez Cancer incidence and mortality in Spain: estimates and projections for the period 1981-2012 Ann Oncol 21 Suppl 3 2010 30 36
5. F.H. Schroder, J. Hugosson, M.J. Roobol, T.L. Tammela, S. Ciatto, and V. Nelen Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 2009 1320 1328
6. M.J. Roobol, M. Kerkhof, F.H. Schroder, J. Cuzick, P. Sasieni, and M. Hakama Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC) Eur Urol 56 2009 584 591
7. J. Hugosson, S. Carlsson, G. Aus, S. Bergdahl, A. Khatami, and P. Lodding Mortality results from the Goteborg randomised population-based prostate-cancer screening trial Lancet Oncol 11 2010 725 732
8. P. Finne, M. Fallah, M. Hakama, S. Ciatto, J. Hugosson, and K.H. de Lead-time in the European Randomised Study of Screening for Prostate Cancer Eur J Cancer 46 2010 3102 3108
9. G.L. Andriole, E.D. Crawford, R.L. Grubb III, S.S. Buys, D. Chia, and T.R. Church Mortality results from a randomized prostate-cancer screening trial N Engl J Med 360 2009 1310 1319
10. H.H. Dubben Trials of prostate-cancer screening are not worthwhile Lancet Oncol 10 2009 294 298
11. A. Heidenreich, J. Bellmunt, M. Bolla, S. Joniau, M. Mason, and V. Matveev Guía de la EAU sobre el cáncer de próstata. Parte I: cribado, diagnóstico y tratamiento del cáncer clínicamente localizado Actas Urol Esp 35 2011 501 514
12. P. Goldberg USPSTF To Downgrade PSA Screening From I to D - As In Dont Do It Cancer Lett 37 2011 1 6
13. N. Lawrentschuk, N. Daljeet, G. Trottier, P. Crawley, and N.E. Fleshner An analysis of world media reporting of two recent large randomized prospective trials investigating screening for prostate cancer BJU Int 108 8 Pt 2 2011 E190 E195
14. F.H. Schroder, L.J. Denis, M. Roobol, V. Nelen, A. Auvinen, and T. Tammela The story of the European Randomized Study of Screening for Prostate Cancer BJU Int 92 Suppl 2 2003 1 13 (Pubitemid 38091131)
15. A. Berenguer, M. Lujan, A. Paez, C. Santonja, and T. Pascual The Spanish contribution to the European Randomized Study of Screening for Prostate Cancer BJU Int 92 Suppl 2 2003 33 38 (Pubitemid 38091137)
16. H.J. De Koning, M.K. Liem, C.A. Baan, R. Boer, F.H. Schroder, and F.E. Alexander Prostate cancer mortality reduction by screening: power and time frame with complete enrollment in the European Randomised Screening for Prostate Cancer (ERSPC) trial Int J Cancer 98 2002 268 273 (Pubitemid 34150812)
17. M. Lujan, A. Paez, C. Pascual, J. Angulo, E. Miravalles, and A. Berenguer Extent of prostate-specific antigen contamination in the Spanish section of the European Randomized Study of Screening for Prostate Cancer (ERSPC) Eur Urol 50 2006 1234 1240 (Pubitemid 44692916)
18. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER Cancer Statistics Review, 1975-2008. Table 23.10 - Cancer of the Prostate (Invasive). Risk of Being Diagnosed With Cancer in 10, 20 and 30 Years, Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age, and Lifetime Risk of Dying from Cancer Given Alive at Current Age. Males, 2005-2007 By Race/Ethnicity. http://seer.cancer.gov/csr/1975-2008/2011 January 1 [citado el 7 de octubre de 2011]. Disponible en: URL: http://seer.cancer.gov/ csr/1975-2008/
19. National Cancer Intelligence Network. Up to half of deaths in men with prostate cancer are directly due to the disease. [consultado el 1 de octubre de 2011]. Disponible en: URL: http://www.ncin.org.uk/view.aspx?rid=660
20. L. Holmberg, D. Robinson, F. Sandin, F. Bray, K.M. Linklater, and A. Klint A comparison of prostate cancer survival in England, Norway and Sweden: A population-based study Cancer Epidemiol 2011 En prensa
21. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2011 69 90
22. Instituto Nacional de Estadística. Defunciones según la Causa de Muerte. Año 2009. [citado el 7 octubre de 2011]. Disponible en: http://www.ine.es/prensa/np664.pdf 2011 July 4
23. Instituto Nacional de Estadística. Esperanza de vida a distintas edades. Brecha de género. España. [citado el 7 de octubre de 2011]. Disponible en: http://www.ine.es/jaxi/tablado?type=pcaxis&path=/t00/ mujeres-hombres/tablas-1/l0/&file=T04002.px 2011 October 1
24. A. Bill-Axelson, L. Holmberg, M. Ruutu, H. Garmo, J.R. Stark, and C. Busch Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer N Engl J Med 364 2011 1708 1717